Nature Communications (Apr 2022)

Construction of emissive ruthenium(II) metallacycle over 1000 nm wavelength for in vivo biomedical applications

  • Yuling Xu,
  • Chonglu Li,
  • Shuai Lu,
  • Zhizheng Wang,
  • Shuang Liu,
  • Xiujun Yu,
  • Xiaopeng Li,
  • Yao Sun

DOI
https://doi.org/10.1038/s41467-022-29572-2
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Ruthenium (Ru(II)) compounds are of interest as platinum drug replacements but have suffered from suboptimal therapeutic efficiency. Here, the authors design a Ru(II) metallacycle with NIR excitation and emission wavelengths and demonstrate application for deep tumour imaging and chemo-photo therapy.